510(k) device
VersaWrap Nerve Protector (VTP-2201)
Alafair Biosciences · Cuff, Nerve (JXI, Class II) · First FDA decision Sep 14, 2020, newest Jul 17, 2025Peripheral neuropathy and nerve injury
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
510(k) pathway
Device trials
5
Naming "VersaWrap"
MAUDE reports
3
Brand "VersaWrap", since 2015
PubMed studies
7
Mentioning "VersaWrap"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing VersaWrap Nerve Protector (VTP-2201)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
K251175 · Decided Jul 17, 2025 · 92 days after receipt
Device type: Cuff, Nerve (JXI) · Neurology & Neurosurgery
K232029 · Decided Nov 2, 2023 · 118 days after receipt
Device type: Cuff, Nerve (JXI) · Neurology & Neurosurgery
K201631 · Decided Sep 14, 2020 · 90 days after receipt
Device type: Cuff, Nerve (JXI) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Vagus Nerve Stimulation (VNS)National determinationOn the books160.18Updated Nov 5, 2026
- Vagus Nerve Stimulation for Treatment of Resistant Depression (TRD)National analysisReview closedCAG-00313RUpdated Sep 24, 2026
- Vagus Nerve Stimulation (VNS) for Treatment Resistant Depression (TRD)National analysisReview closedCAG-00313R2Updated Sep 24, 2026
- Transcutaneous Electrical Nerve Stimulation for Chronic Low Back PainNational analysisReview closedCAG-00429NUpdated Sep 24, 2026
- Cavernous Nerves Electrical Stimulation with Penile PlethysmographyNational analysisReview closedCAG-00311NUpdated Sep 17, 2026
- Sacral Nerve Stimulation for Urge Urinary IncontinenceNational analysisReview closedCAG-00058NUpdated Sep 15, 2026
- Electrodiagnostic Sensory Nerve Conduction ThresholdNational analysisReview closedCAG-00106RUpdated Sep 14, 2026
- Electrodiagnostic Sensory Nerve Conduction ThresholdNational analysisReview closedCAG-00106NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "VersaWrap", any status and sponsor, newest update first.
- Prospective Randomized Blinded Trial of VersaWrap Tendon Protector for Zone 2 Flexor Tendon InjuriesCompleted
University of FloridaAcademic, hospital or other
NCT04322370 · 11 participants · Start Aug 21, 2020 · Primary completion Mar 31, 2026
Device: VersaWrap Treatment · For: Flexor Tendon
Sites: Gainesville, Florida
University of Colorado, DenverAcademic, hospital or other
NCT04976335 · 50 participants (planned) · Start Sep 13, 2021 · Primary completion Jul 2027
Device: Versawrap membrane · For: Distal Radius Fracture; Tendon Rupture
Sites: Aurora, Colorado; Denver, Colorado
Research SourceResearch network
NCT05598801 · 17 participants · Start Sep 1, 2022 · Primary completion Aug 17, 2025
Device: VersaWrap · For: Tendon Repair; Fracture Repair; Tenolysis
Sites: Austin, Texas
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "VersaWrap", and for the whole product code for context.
This brand
3 reports: 0 malfunction, 3 injury, 0 death
Whole product code JXI
127 reports: 19 malfunction, 106 injury, 0 death
Newest reports for this brand
- VERSAWRAPInjury
3012669262-2023-00001 · Received Sep 29, 2023 · Event dated Jul 13, 2023
Device type: Mesh, Surgical (FTM)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Abscess
- VERSAWRAPInjury
3012669262-2023-00003 · Received Sep 29, 2023 · Event dated Aug 7, 2023
Device type: Mesh, Surgical (FTM)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Abscess
- VERSAWRAPInjury
3012669262-2023-00002 · Received Sep 29, 2023 · Event dated Aug 3, 2023
Device type: Mesh, Surgical (FTM)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Abscess
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "VersaWrap"[tiab]. The summary above synthesizes these.
- Perineural Scar Prevention in Brachial Plexus Decompression Surgery: Clinical Outcomes Using a Bioresorbable Hydrogel Implant.
Cervantes Valadez S, Harris P, Cato L, et al. · Hand (N Y) · 2026
- Outcomes following use of VersaWrap nerve protector in treatment of patients with recurrent compressive neuropathies.
Hones KM, Nichols DS, Barker H, et al. · Front Surg · 2023
- Evaluating the effect of VersaWrap tendon protector on functional outcomes in operative tendon repairs.
Adu Y, Harder J, Cox C, et al. · Front Surg · 2024
- A Second Look at the Use of VersaWrap® Nerve Protector in Spine Surgery: A Case Report.
Bruggeman A, Van Schouwen K, Keswani R · Cureus · 2025Case Reports
- Bioresorbable hyaluronic acid alginate hydrogel use in total ankle arthroplasty to control post-operative scarring.
Badell JS · J Surg Case Rep · 2025
- Urological Applications of Novel Hyaluronic Acid/Alginate Gel to Protect Nerves: A Single-Surgeon Experience.
Pham D, Pham B, Ng MK · Cureus · 2025
- Injectable Vancomycin Contained Within a Hyaluronic Acid-Impregnated Alginate Carrier: A Novel Technique for Prophylaxis Against Surgical Site Infection.
Rushing CJ · Cureus · 2026
Other devices of this type
Also filed under product code JXI.
- Neurolac(R) Nerve GuidePolyganics B.V. · 510(k) 2011
- Axoguard HA+ Nerve Protector (AGHA12)Axogen Corporation · 510(k) 2023
- Reaxon PlusMedovent GmbH · 510(k) 2018
- NeuraGen 3D Nerve Guide MatrixIntegra LifeSciences Corporation · 510(k) 2017
- Collagen Nerve WrapCollagen Matrix, Inc. · 510(k) 2006
- SILKBridgeKLISBio S.r.l. · 510(k) 2026
- NeuroSpan BridgeAuxilium Biotechnologies, Inc. · 510(k) 2026
- VersaCoat Nerve Protector (VTP-44G2)Alafair Biosciences · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.